Research ExplorerPublicationsJAK inhibition with ruxolitinib as pretreatment for allogene...

JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis

Standard

JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis. / Stübig, T; Alchalby, H; Ditschkowski, M; Wolf, D; Wulf, G; Zabelina, T; Wolschke, C; Ayuketang, Francis Ayuk; Kröger, N.

In: LEUKEMIA, Vol. 28, No. 8, 01.08.2014, p. 1736-8.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Stübig, T, Alchalby, H, Ditschkowski, M, Wolf, D, Wulf, G, Zabelina, T, Wolschke, C, Ayuketang, FA & Kröger, N 2014, 'JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis', LEUKEMIA, vol. 28, no. 8, pp. 1736-8. https://doi.org/10.1038/leu.2014.86

APA

Stübig, T., Alchalby, H., Ditschkowski, M., Wolf, D., Wulf, G., Zabelina, T., Wolschke, C., Ayuketang, F. A., & Kröger, N. (2014). JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis. LEUKEMIA, 28(8), 1736-8. https://doi.org/10.1038/leu.2014.86

Vancouver

Stübig T, Alchalby H, Ditschkowski M, Wolf D, Wulf G, Zabelina T et al. JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis. LEUKEMIA. 2014 Aug 1;28(8):1736-8. https://doi.org/10.1038/leu.2014.86

Bibtex

@article{f5205e2d14574f5f909c8692f2e62ed2,
title = "JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis",
keywords = "Adult, Aged, Female, Hematopoietic Stem Cell Transplantation, Humans, Janus Kinases, Male, Middle Aged, Primary Myelofibrosis, Pyrazoles, Transplantation, Homologous",
author = "T St{\"u}big and H Alchalby and M Ditschkowski and D Wolf and G Wulf and T Zabelina and C Wolschke and Ayuketang, {Francis Ayuk} and N Kr{\"o}ger",
year = "2014",
month = aug,
day = "1",
doi = "10.1038/leu.2014.86",
language = "English",
volume = "28",
pages = "1736--8",
journal = "LEUKEMIA",
issn = "0887-6924",
publisher = "NATURE PUBLISHING GROUP",
number = "8",

}

RIS

TY - JOUR

T1 - JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis

AU - Stübig, T

AU - Alchalby, H

AU - Ditschkowski, M

AU - Wolf, D

AU - Wulf, G

AU - Zabelina, T

AU - Wolschke, C

AU - Ayuketang, Francis Ayuk

AU - Kröger, N

PY - 2014/8/1

Y1 - 2014/8/1

KW - Adult

KW - Aged

KW - Female

KW - Hematopoietic Stem Cell Transplantation

KW - Humans

KW - Janus Kinases

KW - Male

KW - Middle Aged

KW - Primary Myelofibrosis

KW - Pyrazoles

KW - Transplantation, Homologous

U2 - 10.1038/leu.2014.86

DO - 10.1038/leu.2014.86

M3 - SCORING: Journal article

C2 - 24569777

VL - 28

SP - 1736

EP - 1738

JO - LEUKEMIA

JF - LEUKEMIA

SN - 0887-6924

IS - 8

ER -